Evidence Summary

LGMD2I in a North American population

A genetic screening study identifying FKRP-related LGMD in two North American referral cohorts.

cohortGeneticsDiagnosisClinicians

Citation: Kang PB, Feener CA, Estrella E, et al. LGMD2I in a North American population. BMC Musculoskelet Disord. 2007;8:115.

Key Takeaway

Seven FKRP diagnoses among 87 people evaluated for LGMD illustrate the value of molecular confirmation when clinical presentations overlap.

Main findings

  • Screening cohorts of 63 and 24 people identified four and three FKRP-related LGMD cases, respectively.
  • Six affected participants were homozygous for c.826C>A; the seventh carried two different FKRP variants.
  • Six had relatively mild presentations. One had onset before age three and an uncertain subsequent course; all seven were ambulatory at their last reported follow-up.

Practical relevance

  • Offers historical context for including FKRP in the differential diagnosis of LGMD.
  • Does not determine which modern genetic testing approach is appropriate for an individual.

Limitations and cautions

  • Referral cohorts cannot estimate prevalence across North America.
  • Some participants had not undergone cardiac or respiratory screening, limiting complication estimates.
  • This 2007 diagnostic study does not establish individual prognosis or a surveillance schedule.

Primary Sources

Direct links for verification

Back to Paper Library